Skip to main content
Ching-Hon Pui, MD, Pediatric Hematology & Oncology, Memphis, TN

Ching-HonPuiMD

Pediatric Hematology & Oncology Memphis, TN

Chair and Member, Department of Oncology, St. Jude Children's Research Hospital

Dr. Pui is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Pui's full profile

Already have an account?

  • Office

    St. Jude Children's Research Hospital
    262 Danny Thomas Place
    Memphis, TN 38105

Education & Training

  • University of Tennessee
    University of TennesseeFellowship, Pediatric Hematology/Oncology, 1979 - 1981
  • University of Tennessee
    University of TennesseeResidency, Pediatrics, 1977 - 1979
  • National Taiwan University College of Medicine
    National Taiwan University College of MedicineClass of 1976

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 1978 - 2025
  • OK State Medical License
    OK State Medical License 1977 - 1992
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • America's Top Doctors for Cancer Castle Connolly, 2005-2017
  • Memphis Magazine: Top Doctors Castle Connolly, 2006, 2010-2017
  • Anne T. Bass Endowed Lecture Lucile Salter Packard Children’s Hospital. Stanford University, 2007
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Neurocognitive outcomes among children who experienced seizures during treatment for acute lymphoblastic leukemia  
    Nassar SL, Conklin HM, Zhou Y, Ashford JM, Reddick WE, Glass JO, Laningham FH, Jeha S, Cheng C, Pui CH, Pediatr Blood Cancer, 1/28/2017
  • Impact of sleep, fatigue, and systemic inflammation on neurocognitive and behavioral outcomes in long-term survivors of childhood acute lymphoblastic leukemia  
    Cheung YT, Brinkman TM, Mulrooney DA, Mzayek Y, Liu W, Banerjee P, Panoskaltsis-Mortari A, Srivastava D, Pui CH, Robison LL, Hudson MM, Krull KR, Cancer, 1/27/2017
  • Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report from the St Jude Lifetime Cohort  
    Chemaitilly W, Li Z, Krasin MJ, Brooke RJ, Wilson CL, Green DM, Klosky JL, Barnes N, Clark KL, Farr JB, Fernandez-Pineda I, Bishop MW, Metzger M, Pui CH, Kaste SC, Nes..., J Clin Endocrinol Metab, 1/24/2017
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Germline RUNX1 Variation and Predisposition to T-Cell Acute Lymphoblastic Leukemia in Children
    Ching-Hon Pui, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Identification of New Risk Loci and Regulatory Mechanisms Influencing Genetic Susceptibility to Acute Lymphoblastic Leukaemia
    Ching-Hon Pui, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Lack of Benefit of Extended Vincristine and Dexamethasone Pulses during Maintenance Treatment of Childhood Acute Lymphoblastic Leukemia: A Multicenter Randomized Contr...
    Ching-Hon Pui, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Traumatic and Bloody Lumbar Puncture at Diagnosis in Children with Acute Lymphoblastic Leukemia: A St. Jude Total XV and Total Xvi Cohort Study 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • How the Experts Treat Acute Lymphocytic Leukemia: Case Discussions From Adolescent to Adult 
    60th American Society of Hematology Annual Meeting - 11/30/2018

Other

Press Mentions

  • New Directions in ALL, CML, and CLL Treatment
    New Directions in ALL, CML, and CLL TreatmentOctober 14th, 2024
  • Cellular Therapy Shows Promise in Children with Relapsed Leukemia
    Cellular Therapy Shows Promise in Children with Relapsed LeukemiaDecember 31st, 2022
  • Simultaneous CD19/CD22- CAR T Cell Therapy Resulted in a 99% Complete Response Rate in Children with a Type of Leukemia
    Simultaneous CD19/CD22- CAR T Cell Therapy Resulted in a 99% Complete Response Rate in Children with a Type of LeukemiaNovember 8th, 2022
  • Join now to see all

Professional Memberships